AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo

AHN-GOOK PHARMACEUTICAL Co., Ltd.

Develops and markets medicines, focusing on respiratory and cardiovascular treatments.

001540 | KO

Overview

Corporate Details

ISIN(s):
KR7001540004
LEI:
Country:
South Korea
Address:
경기도 과천시 과천대로7길 12 (갈현동) 프리즘스퀘어2 A동, 과천시

Description

AHN-GOOK PHARMACEUTICAL Co., Ltd. is a pharmaceutical company that develops, manufactures, and markets a broad range of medicines. The company has a strong focus on treatments for the respiratory system and cardiovascular diseases. Its product portfolio includes prescription drugs, over-the-counter medications, and health supplements, with notable products such as Synatura Syrup for respiratory conditions, as well as treatments for digestive and ophthalmic health. The company is dedicated to promoting human health and improving quality of life through the development of innovative and effective pharmaceutical solutions for a global market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.5 MB
2025-06-30 00:00
주식등의대량보유상황보고서(일반)
Korean 94.3 KB
2025-06-05 00:00
주식등의대량보유상황보고서(일반)
Korean 98.9 KB
2025-05-14 00:00
분기보고서 (2025.03)
Korean 1.4 MB
2025-04-21 00:00
주식등의대량보유상황보고서(일반)
Korean 98.4 KB
2025-03-28 00:00
정기주주총회결과
Korean 28.9 KB
2025-03-28 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-20 00:00
감사보고서제출
Korean 25.9 KB
2025-03-20 00:00
사업보고서 (2024.12)
Korean 539.5 KB
2025-03-12 00:00
주주총회집중일개최사유신고
Korean 4.7 KB
2025-03-12 00:00
주주총회소집공고
Korean 114.6 KB
2025-02-24 00:00
주식등의대량보유상황보고서(일반)
Korean 100.2 KB
2025-02-19 00:00
현금ㆍ현물배당결정
Korean 8.4 KB
2025-02-19 00:00
주주총회소집결의
Korean 18.6 KB
2025-02-19 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.5 KB

Automate Your Workflow. Get a real-time feed of all AHN-GOOK PHARMACEUTICAL Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AHN-GOOK PHARMACEUTICAL Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AHN-GOOK PHARMACEUTICAL Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.